✦ LIBER ✦

Rebetron® therapy of chronic hepatitis C patients who were non-responsive to or relapsed on interferon monotherapy-predicting relapse

✍ Scribed by LaBrecque, Douglas R.; Schmidt, Warren N.; Phillips, Mary J. Perino; Schrock, Dawn; Ippolito, Laura; Juhl, Robert; Voigt, Michael D.; Brashear, Donna; Martin, Anthony E.; Adler, Edward C.; Chene, Brenda L.; Tamburro, Carlo H.

Book ID: 123162516
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 190 KB
Volume: 118
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(00)85943-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of rebetron (interferon and rib

Efficacy of rebetron (interferon and ribavirin) combination therapy in the treatment of patients with interferon-refractory or interferon-relapsed chronic hepatitis C

✍ Joseph Greenen E; Daniel Greenen J; Marc Catalano F; Michael Schmalz J 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 28 KB

Low dose ribavirin plus high dose interf

Low dose ribavirin plus high dose interferon for 1 year is effective in the treatment of hepatitis C patients who were initially either relapsers or non-responders to interferon monotherapy

✍ David Bernstein; Maly Tiev; Lennox Jeffers; Gerond Lake-Bakaar 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 41 KB

Management of chronic hepatitis C patien

Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin

✍ D. T. Dieterich; M. Rizzetto; M. P. Manns 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB

13 P Interferon alpha plus ribavirin and

13 P Interferon alpha plus ribavirin and amantadine in chronic hepatitis C patients with previous non response or relapse to interferon and ribavirin

✍ A.Galeota Lanza; T. Ascione; W. Utech; G. Leone; A. Ascione 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Change in hepatitis C virus genotype in

Change in hepatitis C virus genotype in hemodialysis patients after end-of-treatment response to interferon monotherapy—relapse or re-infection?

✍ Teresa C. Arrais; Sonia Van Dooren; Anne-Mieke Vandamme; Christian Brechot; Fran 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

## Abstract Hepatitis C virus (HCV) infection remains common among hemodialysis patients and its occurrence is related mainly to nosocomial spread. Although dialysis patients with HCV infection respond well to interferon‐based therapy, relapse is frequent. This study aimed at a selected group of he

Low dose ribavirin for six months plus i

Low dose ribavirin for six months plus interferon 5 MU TIW for 1 year is effective in the treatment of hepatitis C patients who were initially either relapsers or non-responders to interferon monotherapy

✍ Bernstein, David E.; Jeffers, Lennox; Lake-Bakaar, Gerard 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 161 KB